Breast cancer (PIK3CA testing) (Pilot)
Pilot - Not Accredited
Breast cancer Gene expression profiling Oncotype Dx Prosignia Endopredict
PURPOSE OF PROGRAMME:
Gene expression profiling in breast cancers to determine prognosis.
MATERIAL PROVIDED: FFPE (Formalin Fixed Paraffin Embedded sections)
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: 1
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA